Since Skp2 not only involves in the prognosis of NPC but also regulates the stem cell pool size and biological function of NPC cell line, we propose that Skp2 could be a potential target for NPC therapy. The gene discussed is SKP2; the disease is nasopharyngeal carcinoma.